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rabbit knee, with virtually no damage to other major joint structures,
particularly the extensor mechanism. The preliminary histological results
support this technique as a surgical insult modality for modeling OA
development associated with cumulative abnormal contact stress.
Figure: Histological results. Note: solid squares and bars indicate the
medians and upper/lower quartiles for the control and ACLT data sets.
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EARLY CHANGES FOLLOWING KNEE INJURY IN NON-INVASIVE MOUSE
PTOA MODEL
B. Christiansen, C. Lee, M. Anderson, J. Williams, D.R. Haudenschild.
Univ. of California Davis, Sacramento, CA, USA
Purpose: Symptomatic OA can be deﬁned as the end-stage failure of
load-bearing synovial joints at the organ level. For a knee injury, an
asymptomatic lag phase between the injury and the clinical presentation
of OA can last 10 to 20 years, which means that typical patients are seen
only after extensive and irreversible damage has already occurred. Our
hypothesis is that substantial changes to the cartilage and subchondral
bone occur early after a joint injury. The purpose of this study was to
use a newly developed non-invasive mouse model of knee joint injury
to identify the changes to subchondral bone that occur early after joint
injury.
Methods:Mouse joint injuries were induced in anesthetized mice using a
custom tibial compression jig mounted in a Bose Enduratec instrument.
Mouse tibiae were loaded to 10–12 N at a rate of 1mm/sec, causing
anterior translation of the tibia relative to the distal femur and injuring
the soft tissues of the knee (Figure 1). Mice were euthanized at 1, 3,
7, 14, 28, and 56 days after knee injury, and compared to uninjured
control mice (n =6 per group). Injured and uninjured knees were imaged
using micro-computed tomography (SCANCO mCT35), and the volume of
the trabecular bone analyzed at several locations including the femoral
epiphysis.
Results: Joints were consistently injured at approximately 10–12 N, with
very little variation in the force required for injury. All mice survived
the joint injury well, with no apparent change in activity levels or
obvious signs of discomfort. Analysis of the trabecular bone volume
at the femoral epiphysis and proximal tibial epiphysis showed a rapid
and unexpectedly large loss of trabecular bone after injury, which was
readily detectable at day 3 and reached a maximum loss of >40% BV/TV
(bone volume/total volume) at day 7. This was followed by a period of
partial recovery of bone volume. A more mild but still signiﬁcant loss
of trabecular bone volume was observed in the uninjured contralateral
limbs, which indicates a systemic response to the injury (Figure 2). There
was very little variation in the extent of injury between mice of the same
group, indicating these observations are highly reproducible.
Conclusions: The immediate and signiﬁcant loss of trabecular bone
volume following a relatively mild non-invasive joint injury is a novel
observation. Since OA is initiated at the molecular and cellular level
shortly after injury occurs, the optimal timeframe for therapeutic
intervention may also be shortly after the joint injury. A more thorough
characterization of the early changes in an injured joint will enable
the future design of more accurate OA biomarkers and more effective
therapeutic intervention strategies.
Fig. 1.
Fig. 2.
139
NON-TERMINAL ANIMAL MODEL OF ACUTE JOINT INJURY CAUSES
EARLY OSTEOARTHRITIS
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M.P. Brown2. 1Univ. of Minnesota, St. Paul, MN, USA; 2Univ. of Florida,
Gainesville, FL, USA
Purpose: There is a well recognized need for a translational model of
acute joint injury and early osteoarthritis (OA). Using horses as an acute
injury model has a number of advantages. Athletic stresses on the joint
are similar in humans and horses and the resulting OA lesions also
are similar. The purpose of this study was to develop a non-terminal
equine model that demonstrated clinical and morphological evidence of
the onset and progression of OA. We hypothesized that creation of an
osteochondral (OC) injury in the metacarpophalangeal (MCP) joint of the
horse would result in clinical, radiographic, arthroscopic, and histologic
changes characteristic of early OA.
Methods: Twenty-two clinically and radiographically normal age- and
sex-matched Quarter Horses were randomly divided into 1 of 2 groups:
(1) horses (n =11) that had an OC fragment created arthroscopically on
the proximal dorsomedial aspect of the ﬁrst phalanx in one MCP joint
and a sham operation in the contralateral joint at week 0; and (2)
unoperated exercise control horses (n = 11). All horses were exercised on
a high-speed treadmill 5 days/week from week 2 to week 16. At week
16, OC fragments were arthroscopically removed and small synovial
and cartilage biopsies were taken from OC injured and sham joints.
Every 2 weeks throughout the study, force plate analysis, joint range
of motion, and effusion scores were recorded on all horses and joint
ﬂuid, serum and urine were collected for future biomarker analyses. A
repeated measure ANOVA with Tukey’s for multiple comparison was
used for analysis of clinical data. Week 0 and 16 radiographs (all horses)
and arthroscopic videos (OC injured and sham joints) were blinded and
graded for OA changes. Synovial membrane biopsies obtained from all
OC injured joints at weeks 0 and 16 and from sham joints at weeks 0
(n =5) and 16 (n =11) were blinded and graded histologically, as were
articular cartilage samples obtained from the third metacarpal bone
(opposite OC fragment) at week 16 in OC injured (n =11) and sham (n=6)
joints. All scoring systems except that used for cartilage were analyzed
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using a Kruskal-Wallis test with a Dunn’s multiple comparison test; a
Mann Whitney t test was used for cartilage. P < 0.05 was considered
signiﬁcant. All procedures were approved by institutional animal care
and use committees.
Results: Osteochondral fragments were successfully created and multiple
clinical and morphologic changes consistent with early OA were
demonstrated. OC injured horses exhibited a decrease in forelimb
symmetry (P < 0.001) at week 2 on the force plate, indicating pain. No
further differences were seen over time or between groups. By week 16,
range of motion decreased in 9/11 (82%) OC injured limbs compared to
no change in sham and control limbs. Subjective joint effusion scores
increased in OC injured limbs compared to baseline throughout the
entire study period (P < 0.001). Radiographic scores showed subtle but
signiﬁcant change in the OC injured limbs (Table 1). Arthroscopically,
synovial membrane from OC injured joints exhibited mild changes
(hyperemia, villus thickening, and proliferation). However, cartilage
damage within the joint was more pronounced (Table 1). Histologically,
chondrocyte necrosis and proliferation (repair) were signiﬁcantly greater
in OC injured cartilage compared to sham cartilage, with the majority of
changes restricted to the superﬁcial zone (Table 1). A non-inﬂammatory
ﬁbrotic reaction was seen in OC injured synovium.
Conclusions: Creation of an OC fragment in the equine MCP joint results
in acute traumatic joint injury that has mild but consistent clinical and
morphological features of early OA. This non-terminal injury model will
be useful for deﬁning biomarker changes of early OA and for monitoring
response to therapy of this disease.
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EX-VIVO EFFECTS OF MELOXICAM ON CHONDROCYTE METABOLISM
IN OSTEOARTHRITIC CANINE CARTILAGE
S. Budsberg1, A. Stoker2, S. Johnston1, S. Johnston1, W. Liska3,
L. Reynolds1, J. Cook2. 1Univ. of Georgia, Athens, GA, USA; 2Univ. of
Missouri-Columbia, Columbia, MO, USA; 3Gulf Coast Vet. Specialists,
Houston, TX, USA
Purpose: This study assessed the effect of meloxicam on chondrocyte
metabolism in a naturally occurring osteoarthritic (OA) canine cartilage
model.
Methods: Cartilage harvest from 21 dogs with coxofemoral OA at time of
total hip replacement (THR). Sixteen dogs did not receive NSAIDs prior
to THR and cartilage harvest (Group 1). Five dogs received meloxicam
for at least 14 days prior to THR and cartilage harvest (Group 2).
Cartilage Explant Culturing: Group 1 – Cartilage with control
0.0ug/ml(Cm:control) and meloxicam media dilutions (0.3, 3.0, 30.0
ug/ml): Explants and media were collected on days 3, 12, and 30.
Group 2 – Cultured with culture medium alone (MPM:Cm).
Tissue Matrix Analysis: (1) surgical sample and (1) explant from each
animal in each test group were collected on days 3, 12, and 30 of
culture and analyzed for total sulfated GAG, total collagen content via
hydroxyproline (HP) measurement and cartilage DNA content.
Media Analysis: Chondroitin sulfate 846 (CS-846), Nitric oxide (NO),
Prostaglandin E2 (PGE2), Matrix metalloproteinases (MMP-2, -3, -13),
Aggrecan and Collagen II, Proteinases (MMP-1, -2, -3, -9, -13,
aggrecanase-1, aggrecanase-2), Proteinase inhibitors (TIMP-1, -2, -3),
Inﬂammatory indicators (IL-1b, TNF-a, COX-1, COX-2 and INOS), House
keeping gene (GAPDH)
Statistical Analysis: For comparisons between group 1 subgroups
(Cm:control) and (Mm0.3, Mm3.0, and Mm30.0) where subgroups
included the same dogs, a repeated measures model was utilized.
For comparisons between MPM:Cm, and Cm:control where each group
included different dogs, an analysis of variance (ANOVA) test was used.
Multiple comparisons were adjusted using Tukey’s test. Signiﬁcance level
was set at a = 0.05.
Results:
In vitro:
– Cartilage matrix analysis: Meloxicam had no effect on GAG, HP
or DNA content compared between Cm:control, Mm 0.3, 3.0, 30.0
subgroups at any time point.
– Media analysis: Signiﬁcant changes: GAG decreased in all group1
subgroups on days 12 and 30 compared to day 3. CS-846 decreased
between day 3 and days 12 and 30 in the Cm:control subgroup.
PGE2 was lower on day 3 in all three meloxicam treated subgroups
compared to Cm:control. Aggrecan was greater days 12 and 30
compared to day 0 for the Cm:control group. MMP-3 was decreased
in Mm0.3, 3.0, 30.0 subgroups between days 3 and 30. Aggrecanase-2
was decreased in all group 1 subgroups on all days compared
to baseline. INOS decreased in all group 1 subgroups on all days
compared to day 0.
Ex vivo:
– Cartilage matrix analysis: Meloxicam pretreatment had no effect on
GAG, HP or DNA content compared between Cm:control, at any time
point.
– Media analysis: Meloxicam pretreated cartilage showed no
differences within or between MPM:cm and Cm:control groups in
GAG, HP or DNA content at any time point. NO – increase in MPM:cm
media on day 3 compared to Cm:control. PGE2 – decrease from day 3
to day 30 in both groups. Proteinases – Media MMP-3 concentrations
were less days 12 and 30 compared to day 3 in the MPM:cm group.
Media MMP-13 was greater in MPM:cm compared to Cm:control on
days 3 and 12. Gene Expression – Cm:control MMP2 was increased
days 3, 12, and 30 compared to day 0. MPM:cm group MMP-2 was
lower than Cm:control on days 3 and 12. Inﬂammatory Indicators –
COX-2 gene expression was greater day 3 compared to day 30 in the
MPM:cm group.
Conclusions: These data suggest that meloxicam treatment of naturally
occurring OA cartilage did not induce degradation over 30 days of
treatment and in some measures (media CS-846 and MMP-3) appeared
to prevent degradation at concentrations up to 100 times the expected
synovial concentrations. Meloxicam effectively decreased inﬂammatory
mediator production (PGE2) in OA chondrocytes. Ex-vivo pretreatment
of OA cartilage with meloxicam did not appear to induce degradative
processes in the cartilage as the cartilage was evaluated for 30 days
following removal of drug.
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IN A CANINE IN VIVO MODEL, ARTIFICIALLY ENHANCED
NONENZYMATIC GLYCATION OF CARTILAGE DOES NOT AFFECT
DEVELOPMENT OF OSTEOARTHRITIS UPON MINIMAL SURGICALLY
APPLIED CARTILAGE DAMAGE
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J. Bijlsma1, S. Mastbergen1, F. Lafeber1. 1Rheumatology & Clinical
Immunology, Univ. Med. Ctr. Utrecht, Utrecht, Netherlands; 2Business Unit
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Background: Osteoarthritis is a highly prevalent disease, age being the
main risk factor. The age related accumulation of advanced glycation
endproducts (AGEs) adversely affects the mechanical and biochemical
properties of cartilage.
Purpose: The hypothesis that accumulation of cartilage AGEs predispose
to the development of osteoarthritis was tested in vivo in a canine
model.
Methods: To artiﬁcially increase cartilage AGEs, right knee joints of 8
dogs were repeatedly injected with ribose/threose in PBS, left joints with
PBS alone as a control. Subsequently minimal surgically applied cartilage
damage was induced and loading restrained as much as possible.
Thirty weeks after surgery joint tissues of all dogs were analyzed for
biochemical (PG turnover), macroscopic, and histological features of OA.
The Utrecht University Medical Ethical Committee for animal studies
approved the study.
